copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Jardiance: Uses, Dosage, Side Effects Warnings - Drugs. com Jardiance (empagliflozin) is used to treat type 2 diabetes, chronic kidney disease and reduce the risk of heart failure and cardiovascular disease Includes Jardiance side effects, interactions, and indications
What is Jardiance used for and how does it work? - Drugs. com Key Points Jardiance is a sodium-glucose cotransporter-2 (SGLT-2) inhibitor used with diet and exercise to help control blood sugar and protect the heart in people 10 years of age and older with type 2 diabetes It lowers blood sugar by blocking proteins in the kidney to increase glucose excretion through the urine Jardiance also lowers the risk of a heart-related death (like a stroke or
How does Jardiance help with heart failure? - Drugs. com Jardiance can help with heart failure by improving your heart’s ability to pump blood throughout the body and deliver oxygen to tissues and organs It may do this by reducing sodium (salt) and fluid retention, improving energy use by the heart, reducing inflammation and preventing or reversing cardiac enlargement The exact way that Jardiance helps to treat and prevent heart failure is not
Jardiance Dosage Guide - Drugs. com Detailed dosage guidelines and administration information for Jardiance (empagliflozin) Includes dose adjustments, warnings and precautions
Does Jardiance cause weight loss? - Drugs. com Jardiance is not FDA approved to be used for weight loss in patients without type 2 diabetes, but can lead to weight loss in some patients In clinical trials, Jardiance also led to statistically significant reductions in A1C and fasting plasma glucose, measures of blood sugar control, when compared to an inactive placebo